<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01301261</url>
  </required_header>
  <id_info>
    <org_study_id>Î£-150/03-08-10</org_study_id>
    <nct_id>NCT01301261</nct_id>
  </id_info>
  <brief_title>Sugammadex: Effect on the Awareness Monitoring and Hemodynamics</brief_title>
  <official_title>The Effect of Sugammadex on Hemodynamics, Oxygenation, End-tidal CO2, Entropy and Bispectral Index Intraoperatively Without Steroid Neuromuscular Blocker</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sugammadex is used to reverse the neuromuscular blocking effect of steroid neuromuscular
      blockers. Its cardiovascular effects and effect on brain cortex, if any, may be associated to
      the reversal of the neuromuscular block. The aim of the study was to investigate the pure
      effects of sugammadex in the absence of the agonist.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three groups of patients undergoing elective major surgery and given cis-atracurium for
      muscle relaxation are studied.

      Group 1 receives 2 mg/kg of sugammadex when a count of two of the train of four appears Group
      2 receives 4 mg/kg of sugammadex when a posttetanic count 1-3 appears Group 3 receives 16
      mg/kg of sugammadex three minutes after administration of cis-atracurium.

      Heart rate, arterial blood pressure, oxygen saturation, end-tidal CO2, entropy and bispectral
      index are recorded every three minutes
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Entropy</measure>
    <time_frame>every three minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamics</measure>
    <time_frame>every three minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Surgical Procedure, Unspecified</condition>
  <arm_group>
    <arm_group_label>sugammadex 2 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 mg/kg of sugammadex are given when a response of two counts of train of four are present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 mg/kg of sugammadex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4 mg/kg of sugammadex are given when a posttetanic count 1-3 appears</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugammadex 16 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sugammadex 16 mg/kg are given three minutes after the injection of cis-atracurium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sugammadex</intervention_name>
    <description>Sugammadex 2 mg/kg when a two count of train of four appears</description>
    <arm_group_label>sugammadex 2 mg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex 4 mg/kg</intervention_name>
    <description>Sugammadex 4 mg/kg are given when a posttetanic count 1-3 appears</description>
    <arm_group_label>4 mg/kg of sugammadex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex 16mg/kg</intervention_name>
    <description>Sugammadex 16 mg/kg three minutes after the injection of cis-atracurium</description>
    <arm_group_label>Sugammadex 16 mg/kg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients ASA I-III scheduled for elective major surgery

          -  both sexes

        Exclusion Criteria:

          -  patients hypertensive

          -  treated with antihypertensive drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Argyro Fassoulaki, MD, PhD, DEAA</last_name>
    <phone>+30210 9024530</phone>
    <email>fassoula@aretaieio.uoa.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Konstantinos Chondrogiannis, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology, Aretaieio Hospital</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Argyro Fassoulaki, MD, PhD, DEAA</last_name>
    </contact>
    <contact_backup>
      <last_name>Konstantinos Chondrogiannis</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2011</study_first_submitted>
  <study_first_submitted_qc>February 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2011</study_first_posted>
  <last_update_submitted>June 18, 2012</last_update_submitted>
  <last_update_submitted_qc>June 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Athens</investigator_affiliation>
    <investigator_full_name>Argyro Fassoulaki</investigator_full_name>
    <investigator_title>MD, PhD, DEAA</investigator_title>
  </responsible_party>
  <keyword>Sugammadex</keyword>
  <keyword>entropy</keyword>
  <keyword>bispectral index</keyword>
  <keyword>blood pressure</keyword>
  <keyword>heart rate</keyword>
  <keyword>oxygenation</keyword>
  <keyword>end-tidal CO2</keyword>
  <keyword>hemodynamics</keyword>
  <keyword>general anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cisatracurium</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 14, 2016</submitted>
    <submission_canceled>Unknown</submission_canceled>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

